Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of giving intravenous (IV) gentamicin to
boys with Duchenne muscular dystrophy who have stop codon mutations.
Phase:
Phase 1
Details
Lead Sponsor:
Nationwide Children's Hospital
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH)